Loading...

LYRA LYRA THERAPEUTICS INC Operational Disruptions 8-K Filing

LYR

LYR

LYRA THERAPEUTICS INC

(LYRA)

2023 8-K

Show Summary

Show Summary

Investor Meetings

Reverse Stock Split

Financial Statements

Financial Results

Corporate Presentation

Financial Results

Financial Results

Delisting Notice

Amendment Approval at Annua...

Workforce Reduction Costs

Workforce Reduction

Financial Results Announcement

Management Changes

Financial Results Announcement

Salary Increase

Corporate Presentation

Sublease Agreement

Bylaws Amendments

Financial Results Announcement

Slide Presentation

Equity Offering

Financial Results Announcement

Annual Meeting of Stockholders

Private Placement

Financial Results Announcement

Financial Results Announcement

External Links:

Lyra Therapeutics, Inc. posted a slide presentation with topline results from a clinical study of LYR-220 for chronic rhinosinusitis.

AI Assistant

LYRA THERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.